A detailed history of State Street Corp transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, State Street Corp holds 3,622,335 shares of SNDX stock, worth $68.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,622,335
Previous 4,819,594 24.84%
Holding current value
$68.5 Million
Previous $115 Million 35.17%
% of portfolio
0.0%
Previous 0.01%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$18.82 - $23.79 $22.5 Million - $28.5 Million
-1,197,259 Reduced 24.84%
3,622,335 $74.4 Million
Q1 2024

May 15, 2024

SELL
$19.71 - $24.57 $3.88 Million - $4.83 Million
-196,630 Reduced 3.92%
4,819,594 $115 Million
Q4 2023

Feb 14, 2024

BUY
$11.39 - $21.67 $16.1 Million - $30.7 Million
1,415,576 Added 39.31%
5,016,224 $108 Million
Q3 2023

Nov 14, 2023

SELL
$14.52 - $21.77 $8.04 Million - $12 Million
-553,413 Reduced 13.32%
3,600,648 $52.3 Million
Q2 2023

Aug 14, 2023

BUY
$19.35 - $22.31 $5.57 Million - $6.42 Million
287,831 Added 7.44%
4,154,061 $86.9 Million
Q1 2023

May 15, 2023

BUY
$20.66 - $28.98 $4.5 Million - $6.31 Million
217,767 Added 5.97%
3,866,230 $81.7 Million
Q4 2022

Feb 14, 2023

BUY
$20.64 - $26.24 $21.3 Million - $27.1 Million
1,031,026 Added 39.39%
3,648,463 $92.9 Million
Q3 2022

Nov 15, 2022

BUY
$18.51 - $24.79 $3.37 Million - $4.51 Million
181,920 Added 7.47%
2,617,437 $62.9 Million
Q2 2022

Aug 15, 2022

BUY
$13.64 - $19.48 $752,655 - $1.07 Million
55,180 Added 2.32%
2,435,517 $46.9 Million
Q1 2022

May 16, 2022

SELL
$14.84 - $22.15 $1.48 Million - $2.21 Million
-99,867 Reduced 4.03%
2,380,337 $41.4 Million
Q4 2021

Feb 14, 2022

BUY
$15.23 - $22.47 $5.74 Million - $8.47 Million
376,757 Added 17.91%
2,480,204 $54.3 Million
Q3 2021

Nov 15, 2021

SELL
$13.87 - $19.8 $14.8 Million - $21.1 Million
-1,066,985 Reduced 33.65%
2,103,447 $40.2 Million
Q2 2021

Aug 16, 2021

BUY
$13.42 - $25.18 $6.94 Million - $13 Million
516,961 Added 19.48%
3,170,432 $54.4 Million
Q1 2021

May 17, 2021

BUY
$19.28 - $24.59 $18.4 Million - $23.5 Million
953,751 Added 56.11%
2,653,471 $59.3 Million
Q4 2020

Feb 16, 2021

BUY
$15.1 - $26.44 $8.77 Million - $15.4 Million
581,000 Added 51.93%
1,699,720 $37.8 Million
Q3 2020

Nov 10, 2020

BUY
$13.39 - $17.48 $8.64 Million - $11.3 Million
645,600 Added 136.46%
1,118,720 $16.5 Million
Q2 2020

Aug 14, 2020

BUY
$8.94 - $20.98 $296,968 - $696,913
33,218 Added 7.55%
473,120 $7.01 Million
Q1 2020

May 11, 2020

BUY
$6.65 - $12.03 $2.93 Million - $5.29 Million
439,902 New
439,902 $4.83 Million

Others Institutions Holding SNDX

About Syndax Pharmaceuticals Inc


  • Ticker SNDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,565,200
  • Market Cap $1.07B
  • Description
  • Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...
More about SNDX
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.